prof. Sylvie Rottey
- Work address
-
C. Heymanslaan 10, ingang 12 - verdieping 2
9000 Gent - Sylvie.Rottey@UGent.be
- ORCID iD
-
0000-0003-2060-3725
Show
Sort by
-
The use of national reimbursement reports to support formulary decisions of the hospital's Drug and Therapeutics Committee : a comparative analysis
-
- Journal Article
- A1
- open access
Mental health and quality of life among patients with cancer during the SARS-CoV-2 pandemic : results from the longitudinal ONCOVID survey study
-
- Journal Article
- A1
- open access
Phase I/IIa trial of BMS-986148, an anti-mesothelin antibody–drug conjugate, alone or in combination with nivolumab in patients with advanced solid tumors
-
Cytoreductive nephrectomy and exposure to sunitinib : a post hoc analysis of the immediate surgery or surgery after sunitinib malate in treating patients with metastatic kidney cancer (SURTIME) trial
-
- Journal Article
- A1
- open access
Belgian expert consensus for tumor-agnostic treatment of NTRK gene fusion-driven solid tumors with larotrectinib
-
Novel antibody cocktail targeting Bet v 1 rapidly and sustainably treats birch allergy symptoms in a Phase 1 study
-
- Journal Article
- A1
- open access
Safety and tolerability of topical polyhexamethylene biguanide : a randomised clinical trial in healthy adult volunteers
-
Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID) : a factorial, randomised, controlled trial
-
Immuno-radiotherapy in solid tumors : preliminary results of the randomized phase 2 CHEERS trial
-
Het traject van een patiënt met een hoofd- en halsmaligniteit in België